20-50592370-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001290268.2(RIPOR3):āc.2551G>Cā(p.Val851Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000076 in 1,447,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001290268.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPOR3 | NM_001290268.2 | c.2551G>C | p.Val851Leu | missense_variant | 19/22 | ENST00000327979.8 | NP_001277197.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPOR3 | ENST00000327979.8 | c.2551G>C | p.Val851Leu | missense_variant | 19/22 | 2 | NM_001290268.2 | ENSP00000332663.3 | ||
RIPOR3 | ENST00000045083.6 | c.2539G>C | p.Val847Leu | missense_variant | 19/22 | 5 | ENSP00000045083.2 | |||
RIPOR3 | ENST00000488529.5 | n.874G>C | non_coding_transcript_exon_variant | 6/7 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000760 AC: 11AN: 1447052Hom.: 0 Cov.: 31 AF XY: 0.00000279 AC XY: 2AN XY: 717780
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2024 | The c.2539G>C (p.V847L) alteration is located in exon 19 (coding exon 18) of the FAM65C gene. This alteration results from a G to C substitution at nucleotide position 2539, causing the valine (V) at amino acid position 847 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.